Vertex Pharmaceuticals Incorporated PEG Ratio

The latest PEG ratio for 0QZU.L is 454.7. That is above the Healthcare sector average of 0.46. Investors often review this figure alongside Vertex Pharmaceuticals Incorporated's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 0QZU.L currently prints 454.7 for PEG ratio, while the sector average sits near 0.46. That is roughly 97987.2% above the sector mean. Large gaps often invite a closer look at Vertex Pharmaceuticals Incorporated's growth, margins, and balance sheet.

A PEG ratio of 454.7 for Vertex Pharmaceuticals Incorporated is not 'good' or 'bad' on its own. Compare it with the peer average (0.46) and with 0QZU.L's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 0QZU.L's PEG ratio (454.7), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Vertex Pharmaceuticals Incorporated's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.